Association of oct angle recess width with IOP response after intravitreal triamcinolone injection

Retina

Volumn 33, Issue 2, 2013, Pages 282-286

  Singer, Michael A ^a   Groth, Sylvia L ^b   Sponsel, William E ^a,c   Herro, Angela ^d   Pollard, Joe ^a   Cohen, Steven R ^d   Cohen, Jeffrey H ^a  

^a Medical Center Ophthalmology   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

angle recess; anterior segment ocular coherence tomography; intraocular pressure; intravitreal injection; steroid response; triamcinolone acetonide

Indexed keywords

ANTIHYPERTENSIVE AGENT; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ANGLE RECESS WIDTH; ARTICLE; CALIPER; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; IRIS; MALE; OPTICAL COHERENCE TOMOGRAPHY; PARACENTESIS; PREDICTION; RETROSPECTIVE STUDY; TREATMENT RESPONSE; VISUAL SYSTEM PARAMETERS;

ADULT; AGED; AGED, 80 AND OVER; ANTERIOR EYE SEGMENT; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; RETINAL DISEASES; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TONOMETRY, OCULAR; TRIAMCINOLONE ACETONIDE; YOUNG ADULT;

EID: 84873407402     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182675c72     Document Type: Article

References (14)

1. Hester DE, Trites PN, Peiffer RL, Petrow V. Steroid-induced ocular hypertension in the rabbit: A model using subconjunctival injections. J Ocul Pharmacol 1987;3:185-189.
2. Challa JK, Gillies MC, Penfold PL, et al. Exudative macular degeneration and intravitreal triamcinolone: 18-month followup. Aust N Z J Ophthalmol 1998;26:277-281.
3. Jones R III, Rhee DJ. Corticosteroid-induced ocular hypertension and glaucoma: A brief review and update of the literature. Curr Opin Ophthalmol 2006;17:163-167.
4. Dwinger MC, Pieper-Bodeewes I, Eter N, Holz FG. Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection [in German]. Klin Monbl Augenheilkd 2005;222:638-642.
5. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003;87:24-27.
6. Jonas JB, Kreissig I, Degenring R. Secondary chronic Openangle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol 2003;121:729-730.
7. Jonas JB, Degenrigh RF, Kreissig I, et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 2005;112:593-598.
8. Bakri SJ, Beer PM. The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging 2003;34:386-390.
9. Chan CK, Fan DS, Chan WM, et al. Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: A 6-month follow-up study. Eye 2005;19:625-630.
10. Smithen LM, Ober MD, Maranan L, Spaide RF. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 2004;138:740-743.
11. Ozkirisx A, Erkiliç K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol 2005;40:63-68.
12. Park HY, Yi K, Kim HK. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Korean J Ophthalmol 2005;19:122-127.
13. Wingate RJB, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol 1999; 27:431-435.
14. Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003;110:681-686.